Business Context and Reporting Period
This Form 6-K filing by Nano Dimension Ltd. covers the month of October 2020, specifically dated October 27, 2020. The report details the pricing and terms of a registered direct offering of American Depositary Shares (ADSs).
Key Financial Metrics
The filing focuses on capital raising activities rather than operational performance metrics. Key financial figures include:
- Gross Proceeds: Approximately $50 million.
- Shares Issued: 16,722,000 ADSs.
- Offering Price: $3.00 per ADS.
- Placement Fee: 5.5% of gross proceeds paid to ThinkEquity (Fordham Financial Management, Inc.).
- Warrant Issuance: Warrants to purchase 5.0% of the aggregate ADSs sold (836,100 ADSs) at an exercise price of $3.75 per ADS.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change is the execution of definitive securities purchase agreements on October 26, 2020, to raise capital. The company has agreed to a 30-day lock-up period following the closing of the offering, during which it will not issue or announce the issuance of additional ADSs or ordinary shares, subject to customary exceptions.
Outlook, Risks, and Unusual Items
Closing Timeline: The sale of ADSs is expected to close on or about October 28, 2020, subject to customary closing conditions.
Forward-Looking Statements: The filing includes standard disclaimers regarding forward-looking statements, noting that actual results may differ due to risks including market conditions and the satisfaction of closing conditions.
Risks: Investors are directed to the "Risk Factors" section of the Company's annual report on Form 20-F filed on March 10, 2020, for a comprehensive list of risks.
Investor Verification Checklist
- Confirm the actual closing date of the Registered Direct Offering (expected October 28, 2020).
- Verify the final net proceeds after deducting the 5.5% placement fee and other transaction costs.
- Review the full text of the Placement Agency Agreement and Warrant terms filed as Exhibits 10.1 and 10.1.B.
- Assess the impact of the 16,722,000 new shares on existing shareholder dilution.
- Check subsequent filings for updates on the company's cash position and use of proceeds.